AVACTA Group, which develops technology to test pharmaceutical drugs in the early stages in development, has entered into a collaborative venture with its US partner Pall Corporation to reach new markets.
Pall, a global leader in filtration, separation and purification, will use Avacta’s services and will market joint services in North America and other regions where Avacta is not represented.
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here